In 2021, the value of the platelet-rich plasma market was US$ 370.78 million. With a positive demand outlook, the market is anticipated to grow at a consistent CAGR of 6% through 2031.
According to a review of platelet rich plasma by Future Market Insights, growth prospects are still promising as platelet rich plasma therapy gains popularity in a range of surgical procedures, including aesthetic, orthopaedic, dental, and neurological surgeries.
In-depth medical study is now possible as platelet-rich plasma is used more frequently in surgeries and regenerative therapies. This will boost demand in the platelet rich plasma market along with an increase in sports-related injuries, oral and maxillofacial operations, and periodontal surgery.
Plasmolifting Technologies is a German based company can also offer you Italian PRP tubes as this is one of the core products of this company.
A component of the plasma fraction of autologous blood with a platelet concentration above baseline is known as platelet-rich plasma, or PRP. Orth biologics is a new term for a treatment in the modern health field.
This discipline aims to improve the body’s natural capacity for regeneration and repair. As a safe, non-surgical, biological treatment for osteoarthritis and musculoskeletal rehabilitation, PRP therapy has recently attracted a lot of attention.
The effectiveness of PRP as proposed cannot now be fully confirmed due to a lack of data. To evaluate its effectiveness, additional large randomised controlled trials are required. PRP should therefore be utilised very cautiously right now.
Platelet-rich plasma treatment
Three steps sum up how simple the PRP application process is. The doctor collects the venous blood and sends it to the centrifuge for most orthopaedic use, which is currently done in an outpatient environment.
Depending on automation and centrifuge processing standards, processing blood in a centrifuge typically takes between 5 and 20 minutes, a sterile barrier could be required. The platelet concentration should be increased between four and six times above the baseline concentration, according to the most recent recommendations.
Following centrifugation, the doctor collects PRP in accordance with the device’s instructions. The inclusion of thrombin and calcium chloride, which cause the release of these substances from the alpha granules, activates the platelets gathered in PRP.
With PRP therapy’s increased acceptability, several of its applications are being modified for use during surgery in the operating room.
Pure platelet rich plasma is going to lead the product segment
Pure platelet-rich plasma is anticipated to account for the majority of sales because to benefits like improved wound healing, tissue repair and regeneration, and cost effectiveness, is the prediction in its most recent market assessment.
Recent years have seen an increase in demand for pure platelet rich plasma due to notable advancements in treatment methods overall and the eradication of undesirable side effects. Due to P-potential PRP’s to treat chronic illnesses, various manufacturers have made significant investments in R&D to back up PRP’s health benefit claims.
These medically validated benefits have aided in the creation and development of numerous PRP products, including PRP kits, broadening the potential market.
Additionally, due to growing commercialization of PRP products and expansions in possible uses across sports-related injuries and general procedures, leukocyte-rich platelet-rich plasma will become more significant in some markets.